Castle Biosciences (CSTL) Gross Profit Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 4.04% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 2.86% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 60.04% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 2.33% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 3.75% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 10.79% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.70% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.67% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.71% |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn | 26.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.89% |
| Mar 31, 2026 | 25.62% |
| Dec 31, 2025 | 33.58% |
| Sep 30, 2025 | 31.72% |
| Jun 30, 2025 | 36.17% |
| Mar 31, 2025 | 50.73% |
| Dec 31, 2024 | 50.82% |
| Sep 30, 2024 | 54.64% |
| Jun 30, 2024 | 56.09% |
| Mar 31, 2024 | 44.00% |
| Dec 31, 2023 | 54.27% |
| Sep 30, 2023 | 57.91% |
| Jun 30, 2023 | 54.63% |
| Mar 31, 2023 | 28.46% |
| Dec 31, 2022 | 22.64% |
| Sep 30, 2022 | 29.16% |
| Jun 30, 2022 | 45.88% |
| Mar 31, 2022 | 43.21% |
| Dec 31, 2021 | 26.62% |
| Sep 30, 2021 | 100.31% |